Table 1.
Patient characteristics
| Characteristic | Total (n=270) | Group A (n=120) | Group B (n=150) |
|---|---|---|---|
| Age at diagnosis (yr) | 57 (23–88) | 57 (27–88) | 57 (23–83) |
| Preoperative CA125 level (IU/L) | 409 (6.3–52,940) | 387 (10–52,940) | 451 (6.3–16,873) |
| FIGO stage | |||
| I | 111 (41.1) | 55 (45.8) | 56 (37.3) |
| II | 15 (5.5) | 8 (6.7) | 7 (4.7) |
| III | 87 (34.8) | 36 (30) | 51 (34.0) |
| IV | 57 (21.1) | 21 (17.5) | 36 (24.0) |
| Histology | |||
| High-grade serous | 133 (49.2) | 54 (45.0) | 79 (52.7) |
| Clear cell | 60 (22.2) | 26 (21.6) | 34 (22.7) |
| Endometrioid | 44 (16.2) | 15 (12.5) | 29 (19.3) |
| Mucinous | 16 (5.9) | 11 (9.2) | 5 (3.3) |
| Others | 17 (6.2) | 14 (11.7) | 3 (2.0) |
| Cytoreduction | |||
| R0 | 215 (79.6) | 88 (73.3) | 127 (84.7) |
| R1 | 11 (4.1) | 6 (5.0) | 5 (3.3) |
| R2 | 44 (16.3) | 26 (21.7) | 18 (12.0) |
Values are presented as median (range) or number (%).
CA125, cancer antigen 125; FIGO, International Federation of Gynecology and Obstetrics.